Emerson today announced a collaboration with BioBusiness, an Egyptian medical equipment manufacturing company, to design and manufacture several types of ventilators using Emerson’s ASCO™ valves and AVENTICS™ regulators to provide precise control of pressure and flow of gases.
BioBusiness selected Emerson to work on the new series of ventilators because of the company’s local capabilities in supporting indigenous design and manufacturing standards that meet the stringent requirements of Egypt’s medical industry.
“The battle is far from over. As long as COVID-19 threatens the region and the world, we will continue to innovate and create new solutions to meet the evolving challenges of the virus,” said Eng. Mostafa El Wakeel, BioBusiness CEO. “Emerson’s advanced automation technologies arm us with the weapons necessary to help combat the pandemic and save lives,” he added.
Providing consultancy support on the design of the ventilators, Emerson worked with BioBusiness to build a prototype using ASCO miniature valves and AVENTICS regulators, completing the project ahead of schedule. BioBusiness gave the ventilator the production brand name BIOVENT A Series & E Series. Emerson and BioBusiness are also currently working on an intensive care unit ventilator design and prototype E Series.
“Emerson is proud to support BioBusiness in helping ramp up the manufacturing of life-saving health care devices,” said Khaled Saleh, area director for Egypt, Libya and Sudan at Emerson’s Automation Solutions business. “We will continue to offer our expertise in building such innovations to help the world fight this pandemic.”
Emerson aims to make the world healthier by bringing critical, new life-saving medicines to market faster with consistently high quality. For more information please visit: https://www.emerson.com/en-us/industries/automation/life-sciences-medical
